From Wikipedia, the free encyclopedia
(Redirected from NRG4)
NRG4
Identifiers
Aliases NRG4, HRG4, neuregulin 4
External IDs OMIM: 610894 MGI: 1933833 HomoloGene: 12921 GeneCards: NRG4
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_138573

NM_032002

RefSeq (protein)

NP_612640

NP_114391

Location (UCSC) Chr 15: 75.94 – 76.06 Mb Chr 9: 55.13 – 55.23 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Neuregulin 4 also known as NRG4 is a member of the neuregulin protein family which in humans is encoded by the NRG4 gene. [5] [6] [7]

Function

The neuregulins, including NRG4, activate erb-b2 receptor tyrosine kinase 4 ( ERBB4) to initiating cell signaling through cytosolic tyrosine phosphorylation. [7]

Clinical significance

Loss of expression of NRG4 is frequently seen in advanced bladder cancer while increased NRG4 expression correlates to better survival. [8]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000169752Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000032311Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "Entrez Gene: NRG4 neuregulin 4".
  6. ^ Strausberg RL, Feingold EA, Grouse LH, et al. (December 2002). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode: 2002PNAS...9916899M. doi: 10.1073/pnas.242603899. PMC  139241. PMID  12477932.
  7. ^ a b Harari D, Tzahar E, Romano J, Shelly M, Pierce JH, Andrews GC, Yarden Y (April 1999). "Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase". Oncogene. 18 (17): 2681–9. doi: 10.1038/sj.onc.1202631. PMID  10348342.
  8. ^ Memon AA, Sorensen BS, Melgard P, Fokdal L, Thykjaer T, Nexo E (December 2004). "Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients". Br. J. Cancer. 91 (12): 2034–41. doi: 10.1038/sj.bjc.6602251. PMC  2409781. PMID  15583696.

Further reading